Gamma Glutamyltransferase Reduction Is Associated With Favorable Outcomes in Pediatric Primary Sclerosing Cholangitis.
Document Type
Journal Article
Publication Date
11-1-2018
Journal
Hepatol Commun
Volume
2
Issue
11
Inclusive Pages
1369-1378
DOI
10.1002/hep4.1251
APA Citation
Deneau, M., Mack, C., Abdou, R., Amin, M., Amir, A., Auth, M., Bazerbachi, F., Marie Broderick, A., Chan, A., DiGuglielmo, M., El-Matary, W., El-Youssef, M., Ferrari, F., Furuya, K., Gottrand, F., Gupta, N., Homan, M., Jensen, M., Kamath, B., Mo Kim, K., Kolho, K., Konidari, A., Koot, B., Iorio, R., Martinez, M., Mohan, P., Palle, S., Papadopoulou, A., Ricciuto, A., Saubermann, L., Sathya, P., Shteyer, E., Smolka, V., Tanaka, A., Valentino, P., Varier, R., Venkat, V., Vitola, B., Vos, M., Woynarowski, M., Yap, J., & Miloh, T. (2018). Gamma Glutamyltransferase Reduction Is Associated With Favorable Outcomes in Pediatric Primary Sclerosing Cholangitis.. Hepatol Commun, 2 (11). http://dx.doi.org/10.1002/hep4.1251
Peer Reviewed
1